Dalteparin sodium

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

1567 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Thrombosis	D013927	—	—	9	30	50	45	94	221
Thromboembolism	D013923	HP_0001907	—	7	21	65	37	80	204
Venous thromboembolism	D054556	EFO_0004286	I74	7	18	48	27	67	162
Venous thrombosis	D020246	HP_0004936	I82.40	5	19	34	28	52	134
Covid-19	D000086382	—	—	6	30	30	14	37	103
Embolism	D004617	—	—	6	4	24	26	28	87
Pulmonary embolism	D011655	HP_0002204	I26	7	5	23	26	26	86
Infarction	D007238	EFO_0009463	—	—	4	16	27	24	71
Myocardial infarction	D009203	EFO_0000612	I21	—	3	17	26	23	69
Syndrome	D013577	—	—	7	18	11	11	15	58

Show 176 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Septic shock	D012772	—	A48.3	1	3	2	—	14	20
Cardiovascular diseases	D002318	HP_0001626	—	—	2	4	—	12	18
Healthy volunteers/patients	—	—	—	14	1	1	—	3	18
Multiple myeloma	D009101	—	C90.0	3	5	3	—	4	14
Plasma cell neoplasms	D054219	—	—	3	5	3	—	4	14
Newborn respiratory distress syndrome	D012127	—	P22	2	7	3	—	5	14
Type 1 diabetes mellitus	D003922	EFO_0001359	E10	3	3	2	—	3	11
Pain	D010146	EFO_0003843	R52	—	1	1	—	8	9
Coagulation protein disorders	D020147	—	—	1	—	1	—	5	7
Pathologic constriction	D003251	—	—	—	2	1	—	4	7

Show 104 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Cholangiocarcinoma	D018281	—	C22.1	1	4	—	—	1	6
Coronary stenosis	D023921	EFO_1000882	—	—	1	—	—	4	5
Renal cell carcinoma	D002292	EFO_0000376	—	2	1	—	—	2	4
Carotid artery diseases	D002340	EFO_0003781	—	—	1	—	—	3	4
Cytokine release syndrome	D000080424	—	D89.83	—	1	—	—	3	4
Systemic inflammatory response syndrome	D018746	EFO_1001478	R65.10	—	1	—	—	3	4
Kidney neoplasms	D007680	EFO_0003865	C64	1	1	—	—	2	3
Brain ischemia	D002545	EFO_0003883	I67.82	—	1	—	—	2	3
Somatoform disorders	D013001	—	F45	—	3	—	—	—	3
Hemolysis	D006461	—	—	—	1	—	—	2	3

Show 58 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Blood platelet disorders	D001791	—	—	1	—	—	—	3	4
Congenital heart defects	D006330	HP_0001627	Q24.9	1	—	—	—	2	3
Blood pressure	D001794	EFO_0004325	—	2	—	—	—	—	2
Congenital abnormalities	D000013	EFO_0003915	Q89.9	1	—	—	—	1	2
Systemic lupus erythematosus	D008180	HP_0002725	M32	1	—	—	—	1	2
Neuroblastoma	D009447	EFO_0000621	—	1	—	—	—	1	2
Hearing loss	D034381	EFO_0004238	H91.9	1	—	—	—	1	2
Sensorineural hearing loss	D006319	HP_0000407	H90.5	1	—	—	—	1	2
Deafness	D003638	EFO_0001063	H91.9	1	—	—	—	1	2
Nasopharyngeal carcinoma	D000077274	—	—	1	—	—	—	—	1

Show 25 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Drug-related side effects and adverse reactions	D064420	—	T88.7	—	—	—	—	5	5
Carotid stenosis	D016893	—	—	—	—	—	—	5	5
Postoperative complications	D011183	—	—	—	—	—	—	4	4
Chest pain	D002637	HP_0100749	R07.9	—	—	—	—	4	4
Hypersensitivity	D006967	HP_0012393	T78.40	—	—	—	—	4	4
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	—	—	—	—	4	4
Fatty liver	D005234	EFO_0003934	—	—	—	—	—	4	4
Post-acute covid-19 syndrome	D000094024	—	—	—	—	—	—	4	4
Blood coagulation	D001777	GO_0007596	—	—	—	—	—	3	3
Thoracic aortic aneurysm	D017545	EFO_0004282	—	—	—	—	—	3	3